Long-term control for > 9 years with megestrol acetate-letrozole: metastatic endometrioid carcinoma case report

This is the first case demonstrating that full-dose megestrol acetate plus letrozole may induce durable antitumor activity in HR-high expression metastatic EC, warranting prospective validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-02-24
DOI
https://doi.org/10.3389/fonc.2026.1729721
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term control for > 9 years with megestrol acetate-letrozole: metastatic endometrioid carcinoma case report

Lü Yang, Lixia Liu, Lina Ma, Wenguang He
Frontiers in Oncology
Endometrial and Cervical Cancer Treatments
article

Long-term control for > 9 years with megestrol acetate-letrozole: metastatic endometrioid carcinoma case report

Lü Yang, Lixia Liu, Lina Ma, Wenguang He
article en

Abstract

This is the first case demonstrating that full-dose megestrol acetate plus letrozole may induce durable antitumor activity in HR-high expression metastatic EC, warranting prospective validation.

Frontiers in OncologyVol. 16
Shanxi Medical University (CN), Genetic Analysis (Norway) (NO)
Openalex Percentile: Top 42%
Endometrial and Cervical Cancer Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.